Application of physiologically based pharmacokinetic models to promote the development of veterinary drugs with high efficacy and safety
Kaixiang Zhou,Kun Mi,Wenjin Ma,Xiangyue Xu,Meixia Huo,Samah Attia Algharib,Yuanhu Pan,Shuyu Xie,Lingli Huang
DOI: https://doi.org/10.1111/jvp.12976
IF: 1.567
2021-01-01
Journal of Veterinary Pharmacology and Therapeutics
Abstract:Physiologically based pharmacokinetic (PBPK) models have become important tools for the development of novel human drugs. Food-producing animals and pets comprise an important part of human life, and the development of veterinary drugs (VDs) has greatly impacted human health. Owing to increased affordability of and demand for drug development, VD manufacturing companies should have more PBPK models required to reduce drug production costs. So far, little attention has been paid on applying PBPK models for the development of VDs. This review begins with the development processes of VDs; then summarizes case studies of PBPK models in human or VD development; and analyzes the application, potential, and advantages of PBPK in VD development, including candidate screening, formulation optimization, food effects, target-species safety, and dosing optimization. Then, the challenges of applying the PBPK model to VD development are discussed. Finally, future opportunities of PBPK models in designing dosing regimens for intracellular pathogenic infections and for efficient oral absorption of VDs are further forecasted. This review will be relevant to readers who are interested in using a PBPK model to develop new VDs.